Following separation from its parent company, our pharmaceutical industry client needed comprehensive carve-out support and IPO readiness, including new systems, technical accounting and SEC documentation.
We managed the carve-out execution, converting financials to a new general ledger, supporting general ledger close, delivering technical accounting guidance, preparing audit-ready statements, and contributing to the financial sections of the IPO registration statement.
Our coordinated effort enabled a smooth separation and timely IPO filing, ensuring audit readiness and regulatory alignment to support the client’s transition to an independent public company.
